EcoDrugPlus

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSDCDG00000021427
Gene Symbol: LOC114800573
2 Cross references
194 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSDCDG00000023934
Gene Symbol: LOC114800333
2 Cross references
196 Possible Orthologues:

Mast Cell Protease 1a-Like

Ensembl ID : ENSDCDG00000019070
Gene Symbol: LOC114802536
2 Cross references
1128 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSDCDG00000020603
Gene Symbol: LOC114788906
3 Cross references
208 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSDCDG00000000747
Gene Symbol: MMP13
3 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSDCDG00000031411
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSDCDG00000015570
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSDCDG00000001648
Gene Symbol: LOC114789042
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSDCDG00000000698
Gene Symbol: LOC114799090
3 Cross references
199 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSDCDG00000022253
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSDCDG00000030288
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSDCDG00000028767
Gene Symbol: MC3R
1 Cross references
139 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).